From: Clinical impact of advanced chronic kidney disease in patients with non-HIV pulmonary cryptococcosis
 | eGFR > 45 | eGFR ≤45 | p value |
---|---|---|---|
No treatment | 3 (7.1%) | 2 (14.3%) | 0.44 |
Treatment | |||
 Antifungal drugs | 34/39 (87.2%) | 12/12 (100%) | 0.09 |
 Treatment duration (months) a | 8.9 ± 1.7 | 11.0 ± 2.8 | 0.53 |
 Surgery | 5/39 (12.8%) | 0/12 (0.0%) | 0.09 |
Outcome | |||
 Recovered* | 37/40 (92.5%) | 7/11 (63.6%) | 0.02 |